<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03226964</url>
  </required_header>
  <id_info>
    <org_study_id>1.0</org_study_id>
    <nct_id>NCT03226964</nct_id>
  </id_info>
  <brief_title>Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy</brief_title>
  <acronym>AHOE</acronym>
  <official_title>Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Hospital Galway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University College Hospital Galway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective randomised trial where a computer will randomly allocate

      patients to one of two possible methods of delivering oxygen during the procedure of

      bronchoscopy. This trial compares high flow nasal cannula (HFNC) with nasal prongs in

      delivering oxygen to patients undergoing endo-bronchial ultrasound guided trans-

      bronchial nodal aspiration (EBUS-TBNA) a specialised form of bronchoscopy procedure.

      HFNC uses humidified higher gas flow rates than conventional low flow systems such as

      nasal prongs which are limited by the respiratory rate and effort.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Actual">April 1, 2018</completion_date>
  <primary_completion_date type="Actual">April 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>drop in oxygen saturation during procedure</measure>
    <time_frame>through procedure completion defined as withdrawing scope from patient's mouth, an average of 30 minutes</time_frame>
    <description>the difference in oxygen saturation levels between pre-treatment assessments and the lowest saturation level achieved during treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in venous CO2</measure>
    <time_frame>1 hour after procedure</time_frame>
    <description>Change in venous CO2 1 hour after procedure compared to pre-procedure level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end tidal CO2 during procedure</measure>
    <time_frame>through procedure completion defined as withdrawing scope from patient's mouth an average of 30 minutes</time_frame>
    <description>Measured with tip of scope at lower trachea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient experience measure on a visual analogue scale</measure>
    <time_frame>up to 3 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endotracheal intubation during or post procedure</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Lymphadenopathy</condition>
  <arm_group>
    <arm_group_label>High flow nasal oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Optiflow; Fisher &amp; Paykel, Auckland, New Zealand)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal prongs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>high flow nasal oxygen</intervention_name>
    <description>humidified high flow nasal oxygen</description>
    <arm_group_label>High flow nasal oxygen</arm_group_label>
    <arm_group_label>Nasal prongs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with a peripheral arterial pulse oximetry ≥ 90% breathing room air

          -  Age ≥ 18 years

          -  Able to breathe spontaneously throughout the procedure

        Exclusion Criteria:

          -  Respiratory or cardiac failure

          -  Recent myocardial infarction &lt; 6 weeks ago

          -  On long term oxygen therapy, those with tracheostomy and/ or non-invasive or invasive
             mechanical ventilation

          -  Nasal and/ or nasopharyngeal disease

          -  Inability to give informed consent

          -  Dementia

          -  Hepatic or end stage renal disease

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Breen</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Galway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Galway</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>July 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Hospital Galway</investigator_affiliation>
    <investigator_full_name>Mohammed Ahmed</investigator_full_name>
    <investigator_title>Specialist Registrar in Respiratory Medicine</investigator_title>
  </responsible_party>
  <keyword>endobronchial ultrasound</keyword>
  <keyword>high flow nasal oxygen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

